[1]
Zhuang, B. and Xu, R. 2023. Principle and Progress of Treating Lymphoma with CD22 as Immunotherapy Target. Highlights in Science, Engineering and Technology. 36, (Mar. 2023), 577–584. DOI:https://doi.org/10.54097/hset.v36i.5733.